These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11358284)

  • 1. Biphasic effects of selegiline on striatal dopamine: lack of effect on methamphetamine-induced dopamine depletion.
    Grasing K; Azevedo R; Karuppan S; Ghosh S
    Neurochem Res; 2001 Jan; 26(1):65-74. PubMed ID: 11358284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine-induced modification of dopamine metabolism in cultured striatal astrocytes.
    Kita T; Philbert MA; Wagner GC; Huang J; Lowndes HE
    Pharmacol Toxicol; 1998 Jul; 83(1):36-9. PubMed ID: 9764424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
    Ilani T; Lamensdorf I; Finberg JP
    Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of deprenyl on methamphetamine-induced dopamine depletions.
    Johnson SK; Medina D; Wagner GC
    J Neural Transm Gen Sect; 1992; 89(1-2):123-7. PubMed ID: 1418863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice.
    Dluzen DE; McDermott JL; Anderson LI
    J Neuroendocrinol; 2001 Jul; 13(7):618-24. PubMed ID: 11442776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
    Broening HW; Morford LL; Vorhees CV
    Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of dopamine release by selective inhibitors of MAO-B.
    Finberg JP; Lamensdorf I; Armoni T
    Neurobiology (Bp); 2000; 8(2):137-42. PubMed ID: 11061211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
    Rothblat DS; Schneider JS
    Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice.
    Kita T; Matsunari Y; Saraya T; Shimada K; O'Hara K; Kubo K; Wagner GC; Nakashima T
    Int J Dev Neurosci; 2000 Oct; 18(6):521-30. PubMed ID: 10884597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parity decreases methamphetamine-induced striatal dopaminergic perturbation.
    Dluzen DE
    Neurochem Int; 2011 Aug; 59(2):101-3. PubMed ID: 21693145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid peptides alleviated while naloxone potentiated methamphetamine-induced striatal dopamine depletion in mice.
    Yu L; Kuo YM; Cherng CF
    J Neural Transm (Vienna); 2001; 108(11):1231-7. PubMed ID: 12030189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of adenosine kinase, adenosine deaminase and transport inhibitors on striatal dopamine and stereotypy after methamphetamine administration.
    Gołembiowska K; Zylewska A
    Neuropharmacology; 2000 Aug; 39(11):2124-32. PubMed ID: 10963755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
    Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose selegiline augments striatal ubiquinol in mouse: an indication of decreased oxidative stress or of interference with mitochondrial respiration? A pilot study.
    Götz ME; Dirr A; Burger R; Rausch WD; Riederer P
    J Neural Transm Suppl; 1995; 46():149-56. PubMed ID: 8821050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effects of inhibition of monoamine oxidase and senescence on methamphetamine-induced neuronal damage.
    Wagner GC; Walsh SL
    Int J Dev Neurosci; 1991; 9(2):171-4. PubMed ID: 1905457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice.
    Lewis C; Dluzen DE
    Neurosci Lett; 2008 Dec; 448(1):130-3. PubMed ID: 18852023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimebon attenuates methamphetamine, but not MPTP, striatal dopamine depletion.
    Geldenhuys WJ; Darvesh AS; Dluzen DE
    Neurochem Int; 2012 Jun; 60(8):806-8. PubMed ID: 22710395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.